Clinical characteristics and outcomes of Chronic Hepatitis C (CHC) patients treated with newer Direct-Acting Antiviral (DAA)-based regimens from a large us payer perspective

Autor:	Ami R. Buikema, Stephanie Korrer, A. Goolsby Hunter, Jamie B. Forlenza, Neeta Tandon
Rok vydání:	2015
Předmět:	medicine.medical_specialty Chronic hepatitis business.industry Health Policy Perspective (graphical) Immunology medicine Public Health Environmental and Occupational Health Intensive care medicine business Direct acting
Zdroj:	Value in Health. 18(3)
ISSN:	1098-3015
DOI:	10.1016/j.jval.2015.03.1294
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4606cd262869b0bb6df088f09b7a2fa3 Zobrazit plný text záznamu Full Text from ScienceDirect